EVOQ Remedies Ltd
Ticker: EVOQ
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
5.21
Market Cap
12.97
Debt/Equity
0.0000
ROE %
0.229
PB
0.2913
Promoter %
11.213
Pledge %
0.000
1Y Rev Growth %
124.564
5Y Rev Growth %
9.333
NP Margin %
0.565
NP Margin 5Y Avg %
5.470
Trading Reference
1M Return %
40.608
6M Return %
79.038
1Y Return %
-33.715
% Away 52W High
78.119
% Away 52W Low
146.919
Daily Volume
128000
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Watch
Score 56/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
EVOQ Remedies Ltd is currently trading near a key support level, with recent volume trends indicating potential accumulation. If the stock can maintain above this support, there is a favorable outlook for a move towards the resistance level, supported by the 50-day EMA. However, if it breaks below the support, downside risks may increase significantly.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
M
Mercury Trade Links Ltd
Mercury Trade Links Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
O
Octaware Technologies Ltd
Octaware Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Skyline Ventures India Ltd
Skyline Ventures India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shashank Traders Ltd
Shashank Traders Ltd presents a risky investment opportunity with several concerns in growth consistency and market sentiment.
View details
V
Vikalp Securities Ltd
Vikalp Securities Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
N
Nouveau Global Ventures Ltd
Nouveau Global Ventures Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dhanvantri Jeevan Rekha Ltd
Dhanvantri Jeevan Rekha Ltd shows potential in a growing sector, but inconsistent financial performance and valuation concerns warrant caution.
View details
G
G D L Leasing and Finance Ltd
G D L Leasing and Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
O
OTCO International Ltd
OTCO International Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
K
Kuberan Global Edu Solutions Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
RLF Ltd
RLF Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
View details
W
Wherrelz IT Solutions Ltd
Wherrelz IT Solutions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Chadha Papers Ltd
Chadha Papers Ltd shows potential but faces significant challenges that could impact future performance.
View details
D
Datiware Maritime Infra Ltd
Datiware Maritime Infra Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks that warrant cautious consideration.
View details
G
Gconnect Logitech and Supply Chain Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
S
Symbiox Investment & Trading Co Ltd
The stock presents several risks with limited growth prospects and weak financial metrics, making it a risky investment.
View details
Business Overview
EVOQ Remedies Ltd is a leading player in the Indian pharmaceutical sector, dedicated to enhancing health outcomes through innovative remedies. Catering to a diverse clientele, including healthcare providers and patients, the company focuses on quality and accessibility. With a commitment to research and development, EVOQ is at the forefront of delivering effective healthcare solutions that matter. Their products are designed to improve lives, making healthcare more effective and affordable for all.
- Leading pharmaceutical company in India
- Focus on innovative healthcare solutions
- Commitment to quality and accessibility
- Strong research and development initiatives
- Improving health outcomes for diverse clientele
Investment Thesis
EVOQ Remedies Ltd stands out due to its strong promoter credibility, which instills investor confidence. The company's focus on digital services positions it well for future growth, tapping into the expanding digital healthcare market. With attractive valuations compared to peers, EVOQ presents a compelling investment opportunity for retail investors seeking long-term gains.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital healthcare services.
- Valuation metrics are favorable compared to industry peers.
- Robust business model supports sustainable revenue growth.
- Strategic initiatives align with market trends, ensuring competitive advantage.
Opportunity vs Risk
Opportunities
- Growing demand for wellness products
- Expansion into new markets
- Strong online sales growth
- Innovative product launches
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in wellness sector
- Supply chain disruptions
- Economic downturn affecting consumer spending
Peer Perspective
EVOQ Remedies Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, indicating potential for rerating if it achieves consistent margin stability and accelerates growth in its product pipeline.
Future Outlook
EVOQ Remedies Ltd is well-positioned for growth, driven by innovative product development and expanding market opportunities. Successful execution of its strategic initiatives and effective cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does EVOQ Remedies Ltd do?A: EVOQ Remedies Ltd focuses on developing innovative healthcare solutions and pharmaceutical products.
- Q: Is EVOQ Remedies Ltd listed on Indian stock exchanges?A: Yes, EVOQ Remedies Ltd is listed on the National Stock Exchange and Bombay Stock Exchange.
- Q: What factors influence the stock price of EVOQ Remedies Ltd?A: Factors include market conditions, company performance, regulatory changes, and industry trends.
- Q: How can I invest in EVOQ Remedies Ltd?A: You can invest through a brokerage account that provides access to Indian stock exchanges.
- Q: What are the risks of investing in EVOQ Remedies Ltd?A: Risks include market volatility, company-specific challenges, and changes in the healthcare sector.
📊 Stock Investment Checklist (100 Points)
EVOQ Remedies Ltd • Updated: 2025-09-17 06:38:39
-
10BusinessHighThe sector is growing with increasing demand for healthcare solutions, but the business model lacks a strong competitive moat.
-
10GrowthHighRevenue and profit growth have been inconsistent, with fluctuations in quarterly results.
-
10ProfitabilityHighROE and ROCE are below industry averages, and operating cash flow is not consistently positive.
-
8ValuationHighP/E and P/B ratios are higher than peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are on the lower side.
-
6GovernanceGoodPromoter holding is decent, but there are concerns regarding pledging and transparency.
-
5DriversGoodGrowth drivers are limited, and execution risks are significant due to market competition.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity and mixed price action.
Final Score & Verdict
Score 68 / 100
• Decent
EVOQ Remedies Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100